中文名 | 阿加曲班 |
---|---|
英文名 | Argatroban anhydrous |
中文别名 |
(2R,4R)-4-甲基-1-[N-[(3-甲基-1,2,3,4-四氢-8-喹啉基)磺酰]-L-精氨酰]-2-哌啶甲酸
(2R,4R)-1-[5-[(氨基亚氨基甲基)氨基]-1-氧代-2-[[(1,2,3,4-四氢-3-甲基-8-喹啉基)磺酰基]氨基]戊基]-4-甲基-2-哌啶羧酸 阿各卓泮 |
英文别名 |
Novastan
(2R,4R)-4-Methyl-1-{N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]arginyl}-2-piperidinecarboxylic acid Argatroban (2R,4R)-4-Methyl-1-{N-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl]arginyl}piperidine-2-carboxylic acid (2R,4R)-1-{N-(Diaminomethylene)-N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-ornithyl}-4-methyl-2-piperidinecarboxylic acid 2-Piperidinecarboxylic acid, 1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, (2R,4R)-, hydrate (1:1) (2R,4R)-1-{N-(diaminomethylidene)-N-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl]-L-ornithyl}-4-methylpiperidine-2-carboxylic acid (2R,4R)-4-Methyl-1-{N-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl]-L-arginyl}piperidine-2-carboxylic acid (2R,4R)-1-(5-Carbamimidamido-2-{[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]amino}pentanoyl)-4-methyl-2-piperidinecarboxylic acid MQPA Argipidine (2R,4R)-4-Methyl-1-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-2-piperidinecarboxylic Acid Slonnon [2R-[1(2S*),2a,4b]]-[partial]-1-[5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid 2-Piperidinecarboxylic acid, 1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, (2R,4R)- (2R,4R)-4-Methyl-1-{N-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl}-2-piperidinecarboxylic acid hydrate (1:1) Argatroban monohydrate MFCD00866789 2-Piperidinecarboxylic acid, 1-[(2S)-5-[(diaminomethylene)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, (2R,4R)- Argatroban anhydrous UNII:IY90U61Z3S UNII:OCY3U280Y3 (2R,4R)-4-Methyl-1-[(S)-N2-[[(R,S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl]sulfonyl]arginyl]pipecolic Acid |
描述 | Argatroban是凝血酶选择性抑制剂。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 801.3±75.0 °C at 760 mmHg |
熔点 | 188-1890C |
分子式 | C23H36N6O5S |
分子量 | 508.634 |
闪点 | 438.4±37.1 °C |
精确质量 | 508.246796 |
PSA | 186.09000 |
LogP | 2.56 |
外观性状 | 白色粉末 |
蒸汽压 | 0.0±3.0 mmHg at 25°C |
折射率 | 1.674 |
储存条件 | Store at +4°C |
分子结构 | 1、 摩尔折射率:129.78 2、 摩尔体积(cm3/mol):345.7 3、 等张比容(90.2K):968.8 4、 表面张力(dyne/cm):61.6 5、 极化率(10-24cm3):51.45 |
更多 | 1.性状:从乙醇结晶 2.熔点(ºC):188~191 |
危害码 (欧洲) | Xn,N |
---|---|
风险声明 (欧洲) | R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . R51/53:Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment . |
安全声明 (欧洲) | S28-S61-S28A |
危险品运输编码 | UN 2020 6.1/PG 3 |
WGK德国 | 2 |
RTECS号 | SK2450000 |
包装等级 | III |
危险类别 | 6.1 |
海关编码 | 2935009090 |
~95% 74863-84-6 |
文献:LUNDBECK PHARMACEUTICALS ITALY S.P.A. Patent: WO2009/124906 A2, 2009 ; Location in patent: Page/Page column 20-21 ; |
~90% 74863-84-6 |
文献:Cossy, Janine; Belotti, Damien Bioorganic and Medicinal Chemistry Letters, 2001 , vol. 11, # 15 p. 1989 - 1992 |
~% 74863-84-6 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 15 p. 1989 - 1992 |
~% 74863-84-6 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 15 p. 1989 - 1992 |
~% 74863-84-6 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 15 p. 1989 - 1992 |
~% 74863-84-6 |
文献:Bioorganic and Medicinal Chemistry Letters, , vol. 11, # 15 p. 1989 - 1992 |
上游产品 6 | |
---|---|
下游产品 0 |
海关编码 | 2935009090 |
---|---|
中文概述 | 2935009090 其他磺(酰)胺. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:35.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |